Unyango lweArthritis

Ingqwalasela yeArthritis Medication

Imithi ye-arthritis iye yaxubusha ukuba ithathwa njengonyango "wendabuko". Ekubeni ukuphendula komntu ngamnye kumachiza kuyahluka kwaye ngenxa yeempembelelo ezinobungozi kunye nezimpembelelo ezingathandekiyo nazo ziyimpembelelo, ukufumana umxube osebenzayo kakhulu weyeza-arthritis kunokuba yinkqubo enzima kunokuba ungayilindela. Kufuneka ube nolwazi ngamachiza e-arthritis ahlukeneyo, ukwenzela ukuba wenze isigqibo esinolwazi ngogqirha wakho.

I-NSAID / i-COX-2 Inhibitors

I-NSAID (izidakamizwa ezingekho komzimba ezichasayo) ziphakathi kwezidakamizwa eziqhelekileyo ezisetyenzisiweyo kwaye zisetyenziswa kakhulu. Kukho iintlobo ezintathu ze-NSAID: i-salicylates (zombini i-acetylated [umzekelo, i-aspirin] kunye ne-non-acetylated [umzekelo, Disalcid {salsalate}]), Hlanganisa (i-choline magnesium trisalicylate), kunye neePills zeDoan okanye i-Novasal (i-salesilate yamagesi); iiNSAID zemveli; kunye ne-COX-2 inhibitors ekhethiweyo.

Ii-NSAID zisebenza ngokuthintela umsebenzi we-enzyme, i-cyclooxygenase, yaziwa nangokuthi yi-COX. Uphando luye lwabonisa ukuba kukho iindlela ezimbini ze-cyclooxygenase, ezaziwa njenge- COX-1 kunye ne-COX-2 . Ii-NSAID zichaphazela zombini iifom. I-COX-1 ibandakanyekile ekugcineni izicubu ezinempilo, ngelixa i-COX-2 ibandakanyeka kwindlela yokuvuvukala. I-COX-2 inhibitors ekhethiweyo yaba yi-subset ye-NSAID-kunye neCelebrex (celecoxib) ibe ngowokuqala ukuba i-FDA-yamkelwe ngasekupheleni kweminyaka yama-1990.

IiNSAID zesiNtu ziquka:

I-COX-2 Inhibitors iquka:

Funda: I- NSAIDs - Into Omele Uyazi

DMARD

I-DMARD (izifo ezichasene nezifo ezichasene ne-rheumatic) nazo zibizwa ngokuba "izidakamizwa ezithatha ixesha elide". Uphando luqinisekisile ukusebenza kwe-DMARD ekwenzeni unyango lwe- rheumatoid arthritis , i- psoriatic arthritis , kunye ne- spondylitis engabonakaliyo kunye nokubaluleka kokuqala, unyango oludlulayo usebenzisa i-DMARD. Injongo yokuphathwa nge-DMARD kukunqanda ukunyuka kwesifo nokunqanda umonakalo odibeneyo.

DMARD ziquka:

I-Xeljanz (tofacitinib citrate), i-DMARD yomlomo, yavunywa yi-FDA ngomhla kaNovemba 6, 2012, ukunyanga abantu abadala ngokusebenza ngokuthe ngqo kwi-arthritis esebenzayo enomdla oye waba neempendulo ezinganeleyo, okanye ukunyamezela, ukuba i-methotrexate. I-Xeljanz ngowokuqala kwiklasi yeziyobisi ezibizwa ngokuba yiJAK (Janus kinase) inhibitors.

Funda: Amazwi malunga ne-DMARD

Corticosteroids (Steroids)

I-Corticosteroids okanye i-glucocorticoids, ebizwa ngokuthi "i-steroids," yilezi ziyobisi ezinamandla ezinokunciphisa ukuvuvukala nokuvuvukala ngokukhawuleza. Ezi zi yobisi zihlobene ngokusondeleyo ne-cortisol, i-hormone eveliswa yi-cortex ye-adrenal glands. Ziyalelwe kumanani amaninzi ahlukeneyo kuxhomekeke kwimeko kunye nenjongo yokonyango. Nangona i-steroids ingasetyenziselwa ukulawula ukuvuvukala kwamalungu kunye nezitho kwizifo ezivuthayo, njenge-rheumatoid arthritis, lupus , polymyalgia rheumatica , kunye ne- vasculitis , kuye kwafumanisa ukuba ukusetyenziswa kweziphumo ezibi kakhulu kuya kwandisa kwiqondo eliphezulu okanye ngexesha elide se benzisa.

Oogqirha banokumisela i-short-term, i-dose ephezulu ye-intravenous steroids kwezinye iimeko, okanye ugqirha unako ukulawula injola ye-steroid yangaphakathi kwisigxina esithile, njenge-Kenalog (triamcinolone), ukukunceda ufumane ukukhululeka kwintlungu nokuvuvukala.

Corticosteroids ziquka:

Funda: I- Corticosteroids (i-Steroids) - Yintoni Okufanele Uyazi

Ii-Analgesics (IiNtsholongwane zobuhlungu)

Ama-analgesics azinyango-kunciphisa iziyobisi. Ukulawula intlungu kuyimfuneko ebalulekileyo yokuphatha i-arthritis. Nangona kunjalo, ngokungafani ne-NSAID, imishanguzo ye-analgesic ayinakunqanda ukuvuvukala. I-Acetaminophen (iTylenol) yiyona ndlela isetyenziswa ngayo. Izidakamizwa ezinobuncwane zingasetyenziselwa intlungu eninzi.

Narcotics ziquka:

Funda: Imithi yokuhlaziya - Into omele uyiyazi

Biologic Response Modifiers (Biologics)

I-Biologic Response Modifiers (i-BRMs), ebizwa ngokuba yi- biologics , ivuselela okanye ibuyiselwe amandla omzimba wokulwa nesifo okanye isifo. I-Biologics yiziyobisi ezivela kwimithombo yokuphila ngokuchasene neekhemikhali zenziwe.

Enbrel (etanercept) , Remicade infliximab) , iHumira (adalimumab) , iCimzia (certolizumab pegol) , kunye ne- Simponi (golimumab) ekujoliswe kuyo kwi-TNF-alpha, enye yee- cytokines ezibalulekileyo ezibandakanyeka kwi-rheumatoid arthritis. I-block block ye-TNF (iziyobisi ze-biologic ezibophezela kwi-TNF-alpha) zenza ukuba zingasebenzi, ngaloo ndlela ziphazamise umsebenzi wokuvuvukala kwaye ekugqibeleni zinciphise umonakalo ohlangeneyo.

I-Kineret (anakinra), kunye neziyobisi ze-biologic, ngumdlali we-IL-1. I-Kineret yayiyi-blocker yokuqala yokukhetha i-interleukin-1 (IL-1), iprotheni efunyenwe ngaphezu kwamanye abantu abane-arthritis ye-rheumatoid. Ngokunqanda i-IL-1, iKineret inqanda ukuvuvukala kunye nentlungu ehambelana ne-rheumatoid arthritis. I-Kineret ingasetyenziselwa yedwa, okanye inxulumene namanye ama-DMARD, ngaphandle kweziyobisi ezichasene ne-TNF. Ngoxa i-Kineret iyinketho, akunqabile ukuba imiselwe.

I-Orencia (abatacept) yayiyi-modulator yokuqala yokuvuselela i-T-cell ukuvunyelwa kunyango lwe-rheumatoid arthritis.

I-Rituxan (rituximab) , isicatshulwa somhlaza esithengisa kakhulu umhlaba, i-FDA ivunywe ngo-Matshi 2006 ukuba isetyenziswe kunye kunye ne-methotrexate ukunyanga i-rheumatoid arthritis ngokunciphisa impawu kunye neempawu kubantu abadala abanesifo se-rheumatoid esisisigxina kakhulu kwaye ayiphumelelanga omnye okanye ezininzi izidakamizwa ze-TNF. I-Rituxan yonyango lokuqala lwe-rheumatoid arthritis ejolise ngokukhethekileyo i-CD-positive B-cells.

I-Actemra (tocilizumab) yintsholongwane ye- monoclonal evimbela ukumkela i-interleukin-6 (IL-6), oko kuvimbela i-interleukin-6. I-Actemra ivunyiwe yi-FDA ngomhla kaJan 8, 2010 ukwenzela unyango lwe-arthritis yabantu abadala abakhulayo kubantu abangaphumeleli omnye okanye abaninzi be-block block.

I-Rheumatoid Arthritis Treatment - Iingcebiso ze-ACR

Fibromyalgia Izidakamizwa

Kuze kube ngo-2007, bekungekho namachiza avunywe yi-FDA kunyango lwe- fibromyalgia . Oogqirha baphatha i-fibromyalgia ngeendlela ezahlukeneyo zamachiza eziphuhlisiwe kwaye zavunyelwa ezinye izibonakaliso. Ngo-2007, uLyrica (pregabalin) wamukelwa ukuba aphathe i-fibromyalgia. Ngo-2008, i- Cymbalta (i-duloxetine HCl) yavunywa kwi-fibromyalgia. Ngonyaka ka-2009, i- Savella (i-milnacipran HCl) yavunywa kwimeko.

Gout Drugs

I-Gout yenye yeyona ndlela ibuhlungu kakhulu ye-arthritis. Iyakwazi ukulawulwa ngamachiza, ukutya kunye nokuguquka kwendlela yokuphila. Kukho imiba emithathu yonyango lwama-gout ngamachiza: ama-analgesics, imishanguzo echasayo, kunye neziyobisi ukulawula amanqanaba e-uric acid kunye nokuhlaselwa kwe-gout .

Iziyobisi ngenxa yokutya ziquka:

Osteoporosis Izidakamizwa

I-Osteoporosis yimeko ebonakaliswa ngamathambo aguqayo, anamahloni, aqhelekileyo kubantu abadala, kodwa kwaye ingabangela ingxaki kubantu abaye bathatha i-corticosteroids (steroids) ixesha elide. Kukho iindidi ezininzi zezikhetho ze-osteoporosis: i-estrogens, i-hormone ephazamisayo, i-agents form formation, i-bisphosphonates, kunye nama-molecule e-receptor. Ngokuxhomekeke kwisiphi isilwanyana esisetyenzisiweyo, unokunciphisa ukulahlekelwa kwethambo, ukukhuthaza ukukhula kwethambo, nokunciphisa umngcipheko weentsimbi.

Iziyobisi ngenxa ye-osteoporosis ziquka:

ILizwi

Iinjongo eziphambili zokuphatha i-arthritis nezifo ze-rheumatic ngamayeza ziquka ukulawula intlungu, ukunciphisa ukuvuvukala, ukuphuculwa kokuqhubeka kwesifo, nokulawula imisebenzi yesifo. Kukho ezininzi iintlobo ze-arthritis kunye neziyobisi ezininzi kwiklasi nganye. Oku kwenza ukhetho lwenyango luyinkimbinkimbi. Ukugqiba ukuba yiyiphi imithi okanye ukudibanisa kweyeza unyango kulungile. Kusenokwenzeka ukuba kuthathe isilingo kunye nephutha-kwaye uza kuqhubeka uzama de ube uzive ufumene impendulo eyaneleyo. I-Wellwell iqokelele iinkcukacha ozifunayo ukuze wazi malunga namayeza e-arthritis. Ulwazi olubonelelwe luyakunceda uqonde ukuba kutheni uthabatha unyango oluthathayo kwaye luyakunceda ukuba wenze imibuzo kumgqirha wakho.

> Umthombo:

> Kelley's Bookbook yeRheumatology. Icandelo 8. I-Pharmacology ye-Antirheumatic Drugs. Elsevier. I-ninth edition. Fi kelelwa ngo 07/23/16.